Jennifer Cruz Alicbusan, FNP
Family · Napa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
Offices
1 location
Hospitals listed: 057659 · Providence Queen of the Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Jennifer Cruz Alicbusan’s office at (707) 251-3604 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Providence Queen of the Valley Medical CenterNapa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.107, Oct 2024 – Sep 2025
See every measure and the patient survey for Providence Queen of the Valley Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.107 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.92) · 609 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.5 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 191.43 (130.54 to 252.33) · 39 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12 · 271 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.7 · 376 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 175 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 1,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.41) · 4,152 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,188 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.81 (1.63 to 5.99) · 803 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.21) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.19 (0.62 to 3.77) · 742 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.45 (0.91 to 16) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.58 (1.75 to 9.42) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 152 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.19 (0 to 0.94) · 2,994 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.684 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.887 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 270 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.8 · 143 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.1 · 316 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -1 · 399 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 20.4 · 337 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.5 to 7.8) · 107 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (9.8 to 17.7) · 107 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.4 to 16.2) · 848 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 423 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 40% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$37,387
Medicare paid this office $37,387 for 163 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 116 | $16,440 | $87 |
| Long return visit (40+ min) | 69 | $11,824 | $127 |
| Telephone medical discussion with physician, 21-30 minutes | 33 | $3,723 | $81 |
| New patient visit (60+ min) | 25 | $3,007 | $120 |
Who their Medicare patients are
163 Original Medicare patients in 2024. Average age 75 · Women 56% · Also on Medicaid 19% · Health risk score 1.05. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 74% · Coronary heart disease 25% · Depression 22% · Chronic kidney disease 20% · Diabetes 19% · Heart failure 15% · Cancer 14% · Atrial fibrillation 13% · Stroke 8%.
The office billed $184,415, Medicare allowed $52,671 and paid $37,387; for 388 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 163 | 388 | 75 | 1.05 | $184,415 | $37,387 |
| 2023 | 220 | 472 | 77 | 1.23 | $158,145 | $40,864 |
| 2022 | 155 | 309 | 76 | 1.23 | $95,267 | $25,365 |
| 2021 | 247 | 599 | 76 | 1.30 | $106,618 | $51,116 |
| 2020 | 187 | 509 | 76 | 1.58 | $48,634 | $19,075 |
| 2019 | 257 | 444 | 77 | 1.54 | $63,719 | $28,102 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 204 | $33,347 | $88 |
| Long return visit (40+ min) | 28 | $4,166 | $130 |
2022: 4 services
| Return visit (30+ min) | 100 | $13,873 | $92 |
| Telephone medical discussion with physician, 21-30 minutes | 41 | $3,878 | $79 |
| Short return visit (20+ min) | 27 | $1,865 | $67 |
| Long return visit (40+ min) | 12 | $1,516 | $126 |
2021: 7 services
| Return visit (30+ min) | 172 | $29,675 | $89 |
| Long return visit (40+ min) | 42 | $8,685 | $128 |
| Short return visit (20+ min) | 59 | $4,151 | $55 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 18 | $2,264 | $126 |
| Telephone medical discussion with physician, 21-30 minutes | 22 | $2,170 | $99 |
| Influenza vaccine split virus, preservative free | 11 | $709 | $64 |
| Administration of influenza virus vaccine | 12 | $206 | $17 |
2020: 3 services
| Return visit (30+ min) | 82 | $8,247 | $74 |
| Short return visit (20+ min) | 96 | $6,246 | $52 |
| Long return visit (40+ min) | 20 | $2,288 | $95 |
2019: 5 services
| Return visit (30+ min) | 144 | $13,968 | $83 |
| Short return visit (20+ min) | 98 | $5,991 | $55 |
| Long return visit (40+ min) | 24 | $2,765 | $111 |
| Influenza vaccine split virus, preservative free | 29 | $1,592 | $55 |
| Administration of influenza virus vaccine | 31 | $600 | $19 |
Drugs they prescribed that Part D paid
$38,608
Pharmacies billed $38,608 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
787 generic and fewer than 11 brand-name prescriptions · $38,608 in drug cost · 32 antibiotic prescriptions to 28 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Albuterol Sulfate Hfa | 21 | $696 | $33 |
| Levothyroxine | 69 | $614 | $9 |
| Venlafaxine Hcl Er | 12 | $415 | $35 |
| Atorvastatin | 61 | $353 | $6 |
| Losartan | 26 | $295 | $11 |
See all 21 drugs
| Albuterol Sulfate Hfa | 21 | $696 | $33 |
| Levothyroxine | 69 | $614 | $9 |
| Venlafaxine Hcl Er | 12 | $415 | $35 |
| Atorvastatin | 61 | $353 | $6 |
| Losartan | 26 | $295 | $11 |
| Simvastatin | 25 | $247 | $10 |
| Amlodipine Besylate | 56 | $228 | $4 |
| Tamsulosin | 21 | $214 | $10 |
| Gabapentin | 14 | $197 | $14 |
| Sertraline | 21 | $197 | $9 |
| Pantoprazole | 13 | $146 | $11 |
| Clopidogrel | 11 | $142 | $13 |
| Alendronate | 11 | $122 | $11 |
| Citalopram Hbr | 16 | $99 | $6 |
| Lisinopril | 17 | $93 | $5 |
| Baclofen | 14 | $61 | $4 |
| Metformin Hcl Er | 15 | $59 | $4 |
| Pravastatin | 12 | $43 | $4 |
| Hydrochlorothiazide | 21 | $34 | $2 |
| Metformin | 23 | $34 | $1 |
| Prednisone | 12 | $14 | $1 |
Year by year
| 2024 | 866 | 185 | None | None | $38,608 |
| 2023 | 628 | 187 | None | None | $32,642 |
| 2022 | 670 | 182 | None | None | $30,665 |
| 2021 | 944 | 198 | 4% (33) | None | $60,330 |
| 2020 | 428 | 133 | 5% (20) | 19% | $35,498 |
| 2019 | 145 | 81 | None | 19% | $5,073 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Levothyroxine | 46 | $692 | $15 |
| Albuterol Sulfate Hfa | 19 | $552 | $29 |
| Losartan | 16 | $436 | $27 |
| Omeprazole | 14 | $414 | $30 |
| Tamsulosin | 12 | $364 | $30 |
| Sertraline | 24 | $354 | $15 |
| Atorvastatin | 44 | $353 | $8 |
| Pravastatin | 17 | $337 | $20 |
| Amlodipine Besylate | 35 | $216 | $6 |
| Gabapentin | 12 | $173 | $14 |
| Lisinopril | 18 | $115 | $6 |
| Hydrochlorothiazide | 24 | $69 | $3 |
| Prednisone | 21 | $51 | $2 |
2022: 15 drugs
| Levothyroxine | 61 | $1,038 | $17 |
| Albuterol Sulfate Hfa | 30 | $953 | $32 |
| Atorvastatin | 32 | $551 | $17 |
| Omeprazole | 24 | $412 | $17 |
| Gabapentin | 22 | $408 | $19 |
| Tamsulosin | 13 | $367 | $28 |
| Lisinopril | 33 | $350 | $11 |
| Amlodipine Besylate | 30 | $246 | $8 |
| Duloxetine | 13 | $233 | $18 |
| Metformin | 14 | $227 | $16 |
| Losartan | 14 | $180 | $13 |
| Alendronate | 20 | $165 | $8 |
| Prednisone | 13 | $165 | $13 |
| Furosemide | 12 | $64 | $5 |
| Hydrochlorothiazide | 12 | $48 | $4 |
2021: 23 drugs
| Eliquis | 14 | $17,778 | $1,270 |
| Levothyroxine | 96 | $2,327 | $24 |
| Bupropion Xl | 12 | $1,255 | $105 |
| Atorvastatin | 52 | $1,049 | $20 |
| Albuterol Sulfate Hfa | 18 | $670 | $37 |
| Potassium Chloride | 15 | $513 | $34 |
| Tamsulosin | 14 | $495 | $35 |
| Lisinopril | 46 | $465 | $10 |
| Sertraline | 31 | $443 | $14 |
| Metformin | 24 | $422 | $18 |
| Oxycodone | 15 | $403 | $27 |
| Fluticasone Propionate | 20 | $360 | $18 |
| Allopurinol | 11 | $333 | $30 |
| Amlodipine Besylate | 27 | $322 | $12 |
| Omeprazole | 18 | $307 | $17 |
| Losartan | 17 | $287 | $17 |
| Escitalopram | 11 | $282 | $26 |
| Gabapentin | 21 | $261 | $12 |
| Alendronate | 22 | $180 | $8 |
| Furosemide | 15 | $167 | $11 |
| Prednisone | 23 | $143 | $6 |
| Simvastatin | 11 | $115 | $10 |
| Alprazolam | 15 | $28 | $2 |
2020: 6 drugs
| Eliquis | 12 | $8,226 | $685 |
| Levothyroxine | 33 | $956 | $29 |
| Albuterol Sulfate Hfa | 13 | $581 | $45 |
| Atorvastatin | 20 | $560 | $28 |
| Metformin | 23 | $292 | $13 |
| Amlodipine Besylate | 11 | $87 | $8 |
2019: 1 drug
| Prednisone | 11 | $28 | $3 |
Money from drug and device companies
$75 in 2025
| 2025 | 3 | 3 | None | $75 |
| 2024 | 1 | 1 | None | $22 |
| 2023 | 1 | 1 | None | $106 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Inspire Medical Systems | Inspire | $39 | 1 payment
|
| Amgen | Evenity | $22 | 1 payment
|
| Novo Nordisk | Ozempic | $14 | 1 payment
|
See all 3 published payments
| Novo Nordisk | Meals · 2025-02-13 | Ozempic | $14 |
| Amgen | Meals · 2025-01-16 | Evenity | $22 |
| Inspire Medical Systems | Meals · 2025-01-09 | Inspire | $39 |
See earlier years (2024, 2023)
2024: $22
| Dexcom | Dexcom G6 Transmitter | $22 | 1 payment
|
2023: $106
| Medtronic | Micra | $106 | 1 payment
|
Professional record
- NPI
- 1619435815
- Licence
- CA 95011187
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X); Nurse practitioner (363L00000X)
- Mailing address
- 202 Cinnabar Way, Hercules, CA, 94547
- NPI first listed
- 2019-03-06
- NPI last updated
- 2021-10-14
- NPI record certified
- 2021-10-14
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.